Entity

Colorectal Cancer

Cancer of the colon or rectum — among the most common cancers worldwide and a major focus of screening and drug development.

As of 23 Oct 2026Last evidence 22 Oct 2026

What is happening now

FDA grants accelerated approval to dostarlimab for locally advanced rectal cancer
Reported claim · first reported 19 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers

All 1 event and claims involving Colorectal Cancer

What changed

Attention Rising: 63 mentions on 22 Oct 2026, against 44 on 29 Sept 2026 (+43%).
State Last recorded change: coverage state went from rising to steady on 22 Oct 2026 (9 changes recorded since 13 Oct 2026).
Claims No claim first reported since 22 Oct 2026.

How well we know this

1,803 documents · 405 publishers · 7% contain a typed assertion · last evidence 22 Oct 2026

Gap: assertion coverage 0.067: about 93% of mentions carry no typed assertion

In this snapshot’s daily coverage:

Reported alongside Colorectal Cancer

Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.

Immunotherapy · 306 shared documents
KRAS · 150 shared documents
ctDNA · 131 shared documents · no page of its own yet
AI · 101 shared documents
FDA · 101 shared documents
Braf · 91 shared documents · no page of its own yet
Lung Cancer · 80 shared documents · no page of its own yet
Egfr · 78 shared documents · no page of its own yet
MSI-H · 76 shared documents · no page of its own yet
China · 75 shared documents

Story momentum

Rising

The word compares 63 mentions on 22 Oct 2026 with 44 on 29 Sept 2026 (+43%); a change of less than 8% either way reads Steady.

Daily mentions +19% from 7 Sept 2026 to 22 Oct 2026, between 35 and 158 a day

How often tracked coverage mentions Colorectal Cancer, day by day.

Market price, cited

Not priced yet

No open prediction market prices a question materially about Colorectal Cancer yet. Ask about Colorectal Cancer

No market price on file: no prediction market prices a question about this name yet

Coverage volume and market price are separate measures.

On the desk: Health & Bio Desk

For developers

This page is also an object: GET https://sigb.ai/api/v1/node/e/e65e9524bedac8b311cd8e6e returns the same record as sb.node.v1. Or call the get_entity MCP tool at https://sigb.ai/api/mcp with name colorectal cancer.

{
  "name": "colorectal cancer",
  "label": "Colorectal Cancer",
  "asOf": "2026-10-23",
  "mentions": 63,
  "domains": 15,
  "node": {
    "id": "sb:e/e65e9524bedac8b311cd8e6e",
    "schema": "sb.node.v1",
    "rest": "https://sigb.ai/api/v1/node/e/e65e9524bedac8b311cd8e6e",
    "knowledgeCutoff": "2026-10-23T15:03:43.007622+00:00",
    "snapshot": "this deploy's committed data files (commit not exposed in this runtime)"
  },
  "coverageTrend": "rising",
  "history": {
    "since": "2026-10-13T13:19:04.891662+00:00",
    "changes": 9
  },
  "whereFrom": {
    "level": "counts",
    "label": "63 mentions across 15 domains",
    "children": [
      {
        "level": "reports",
        "label": "6 reports drawn on this page, each with its link",
        "children": {
          "count": 6,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "domains",
        "label": "15 coverage domains",
        "children": {
          "count": 15,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "not shown",
        "label": "The other 57 mentions",
        "edge": "counted daily from tracked coverage; single mentions are not listed one by one"
      }
    ]
  }
}

The figures on this page, as data. The tool returns the full entity record.

Events involving Colorectal Cancer

Most-reported first, then newest. Registered events come from the event record; reported events are groups of claims about one occurrence. Claims are grouped when they were first reported within 2 days of each other and either name at least 2 of the same people, places or things besides this one, or share at least 25% of their wording. Each claim keeps its own record.

FDA grants accelerated approval to dostarlimab for locally advanced rectal cancer
Reported claim · first reported 19 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers
corroborated

Walk the record from Colorectal Cancer

Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.